Boehringer Sues Barr Over Generic Stroke Drug
Boehringer Ingelheim Pharma GmbH & Co. KG has filed a patent infringement suit against generic drugmaker Barr Pharmacuticals Inc. to prevent the release of a copycat drug prescribed to lower the...To view the full article, register now.
Already a subscriber? Click here to view full article